ArticleCancer medicine2018

BCR-ABL1 transcript levels at 4 weeks have prognostic significance for time-specific responses and for predicting survival in chronic-phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors.

Hye-Young Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.